Rabeprazole: A comprehensive profile

Profiles Drug Subst Excip Relat Methodol. 2021:46:137-183. doi: 10.1016/bs.podrm.2020.07.003. Epub 2020 Aug 13.

Abstract

Rabeprazole belongs to the class of anti-secretory drugs, with benzimidazoles substitution. These drugs induce gastric acid secretion through precise inhibition of the enzyme H+/K+-ATPase (acid or proton pump). This effect helps to treat and prevent conditions in which gastric acid directly aggravates symptoms such as duodenal and gastric ulcers. This chapter includes a comprehensive review of rabeprazole in terms of nomenclature, its physical-chemical properties, methods of preparation and ADME profiles. In addition, the chapter also includes a review of several methods for analysis of rebeprazole in its dosage forms and biological fluids.

Keywords: ADME profile; Acid or proton pump; Analytical profile; Anti-secretory drugs; Inhibition of the enzyme H(+)/K(+)-ATPase; Methods of synthesis; NMR; Physical description; Rabeprazole; Stability solid-state.

MeSH terms

  • Anti-Ulcer Agents* / pharmacology
  • Gastric Acid
  • Humans
  • Proton Pump Inhibitors* / pharmacology
  • Rabeprazole / pharmacology*

Substances

  • Anti-Ulcer Agents
  • Proton Pump Inhibitors
  • Rabeprazole